scispace - formally typeset
J

Jian Wang

Researcher at Shenyang Pharmaceutical University

Publications -  194
Citations -  2673

Jian Wang is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Pharmacophore & Docking (molecular). The author has an hindex of 22, co-authored 169 publications receiving 1745 citations.

Papers
More filters
Journal ArticleDOI

LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells

TL;DR: It is found that LCH-7749944, a novel and potent PAK4 inhibitor, effectively suppressed the proliferation of human gastric cancer cells through downregulation ofPAK4/c-Src/EGFR/cyclin D1 pathway.
Journal ArticleDOI

Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress.

TL;DR: It is demonstrated that NK not only effectively prevented xylene-induced ear oedema in mice, but also remarkably protected against LPS-induced acute kidney injury in mice through restraining inflammation and oxidative stress, a central player in the initiation and progression of inflammation.
Journal ArticleDOI

Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors

TL;DR: A number of 5-phenylisoxazole-3-carboxylic acid derivatives were synthesized and analyzed for their ability to inhibit xanthine oxidase, and the presence of a cyano group at the 3-position of phenyl moiety turned out to be the preferred substitution pattern.
Journal ArticleDOI

Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.

TL;DR: Lineweaver-Burk plot analysis revealed that representative compound 4f acted as a mixed-type inhibitor for xanthine oxidase, rationalized by its molecular docking into the active site ofxanthine dehydrogenase.
Journal ArticleDOI

Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents.

TL;DR: The SAR analyses indicated that compounds with 4-morpholino group at the C-4 position of thieno[3,2-d]pyrimidine moiety exhibited superior activities than compounds bearing chain amino groups, and compounds with mono-methoxy group atThe 3-position or dimethyl groups at the 3,5-position on the terminal phenyl ring were more active.